Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
Clinical trial NCT00532857 · COMPLETED
Trial details
- NCT number
- NCT00532857
- Sponsor
- Jungsil Ro
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-02-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.